If you have ever spent a weekend cross-referencing 400 PubMed abstracts against a NICE submission template, you know the specific kind of burnout that defines Health Economics and Outcomes Research (HEOR). It is a field where precision is mandatory, but the process is often a manual slog through fragmented data sources. The arrival of an automated agent specifically designed for this niche is not just a curiosity; it is a necessity for teams trying to keep pace with the accelerated drug approval timelines of 2026.

The heor agent ai for health economics research from claude is not a shiny new web app with a colorful dashboard. It is something much more utilitarian and, frankly, more useful: a Model Context Protocol (MCP) server. It acts as a bridge, giving Claude the specific "hands" it needs to reach into healthcare databases and pull out the raw materials for a Health Technology Assessment (HTA). After a week of testing its limits, it is clear that while it won't replace your lead economist, it will certainly make their life less miserable.

What Exactly Is the HEOR Agent for Claude?

heor agent ai for health economics research from claude is a health-economics-focused Model Context Protocol server that automates literature reviews across 41 data sources and generates HTA dossiers for agencies like NICE and the FDA β€” serving as a specialized bridge between Claude’s reasoning and rigorous pharmaceutical research workflows.

Developed by neptun2000 and hosted on GitHub, this tool is built for a very specific audience: pharmaceutical companies, biotech startups, and Contract Research Organizations (CROs). It exists because general-purpose AI models are notoriously bad at the "last mile" of specialized research. They hallucinate citations, they don't understand the nuances of an IQWiG submission, and they certainly can't build a Markov model from scratch without help. This agent provides that help by exposing a suite of tools directly to Claude, allowing the AI to query real-time data and follow standardized regulatory workflows.

Why specialized AI agents are dominating the 2026 enterprise landscape

Where heor agent ai for health economics research from claude Shines β€” and Where It Frustrates

The 41-Source Literature Review Engine

The most immediate value proposition here is the automation of systematic literature reviews. The agent can query 41 different data sources simultaneously. In a typical workflow, a researcher might spend days jumping between PubMed, Cochrane, and various clinical trial registries. With this MCP server, you can simply ask Claude to "Identify all Phase III trials for GLP-1 agonists in adolescent populations published between 2022 and 2025."

The agent doesn't just return a list of links. It parses the data into a persistent project knowledge base. This means that as you continue your research, the agent "remembers" the specific data points found earlier, preventing the repetitive context-window flushing that plagues standard AI chats. It is a massive time-saver, though you still need to manually verify the high-stakes data points. Trusting an AI with a billion-dollar drug submission without a human-in-the-loop is still a recipe for disaster.

Automated HTA Dossier Preparation

Writing a dossier for NICE (UK), the EMA (EU), or the FDA (US) is a masterclass in bureaucratic endurance. Each agency has its own idiosyncratic requirements for evidence presentation. The heor agent ai for health economics research from claude includes templates and logic for these specific bodies, including the EU JCA (Joint Clinical Assessment) and HAS (France).

When you trigger a dossier workflow, the agent pulls from its knowledge base to populate the required sections. It is particularly good at the "Clinical Effectiveness" sections, where it can summarize trial data into the specific formats these agencies demand. However, the "Cost-Effectiveness" modeling is where things get a bit more experimental. While the documentation claims "state-of-the-art modeling," the output is often a framework that requires a human economist to finalize in Excel or R. It gets you 70% of the way there, but that final 30% remains the domain of experts.

The MCP Integration: A Developer's Dream, A Layman's Hurdle

Because this is an MCP server, it lives inside your Claude environment (Claude.ai or Claude Code). This is great because your data stays within the secure environment you've already vetted. There is no new "SaaS" to sign up for. But this also means you need to know how to use a terminal. If you aren't comfortable with npx commands or editing a JSON config file, you will hit a wall before you even start. This is a tool built for teams that have at least one person who knows their way around a GitHub repository.

Your First 15 Minutes With heor agent ai for health economics research from claude

Getting started is surprisingly fast if you are already using Claude Code. You simply run claude mcp add heor-agent -- npx heor-agent-mcp and restart the environment. If you are using the Claude Desktop app, you will need to manually add the server to your claude_desktop_config.json file. This is the part where most non-technical researchers will trip up.

Once it is running, you don't "open" the agent. You just talk to Claude. You might say, "Using the HEOR agent, start a new project for a cost-utility analysis of Drug X." Claude will then recognize the intent and call the relevant tools from the MCP server. It feels like Claude suddenly went to medical school and got a PhD in economics overnight. The first 15 minutes are usually spent in awe of how much "hidden" data the agent can suddenly see.

Pricing Breakdown: What Does It Actually Cost?

Pricing for the heor agent ai for health economics research from claude is not publicly listed in a traditional "Standard/Pro/Enterprise" table. Since it is hosted on GitHub by neptun2000, the core code is accessible via the repository, but implementation in a corporate environment usually involves specific licensing or consulting for the data source APIs it connects to.

You have to account for three separate costs:

  1. Claude Subscription/API: You need a Claude Pro or Team account to use MCP servers effectively.
  2. Data Source Access: While the agent can query 41 sources, some of those databases require their own institutional subscriptions (e.g., certain proprietary medical journals or premium trial databases).
  3. Infrastructure: If you are running this locally, it's "free." If you are deploying it across a global Medical Affairs team, you'll be looking at internal dev-ops costs.
For the most current pricing or enterprise support, you should check the official GitHub repository.

Who Should Use This (and Who Should Skip It)

Use this if: You are a health economist or medical writer at a mid-to-large biotech firm. You are drowning in literature reviews and need a way to synthesize data across multiple regulatory templates. You already use Claude and want to make it more specialized for your daily workflow.

Skip this if: You are a solo practitioner who isn't comfortable with command-line tools. If you only do one HTA a year, the setup overhead isn't worth it. Also, if your organization has a total ban on AI-assisted writing for regulatory submissions, this tool is a non-starter, regardless of how "auditable" it claims to be.

Where heor agent ai for health economics research from claude Shines β€” and Where It Frustrates

What Works What Doesn't
Massive reduction in time spent on systematic literature reviews. Setup requires technical knowledge of MCP and terminal commands.
Direct integration with NICE, EMA, and FDA templates. Cost-effectiveness models still require heavy human auditing.
Persistent knowledge base prevents "AI amnesia" during long projects. Dependent on the stability of 41 different external data APIs.
Auditable workflows make it easier to track evidence provenance. Limited visual UI; everything happens within the Claude chat interface.
Supports the new EU JCA requirements, which are a headache for many. Occasional latency when querying multiple deep-web medical sources.

The Competitive Landscape: How It Compares

The HEOR space has traditionally been dominated by legacy software like TreeAge or specialized platforms like Cytel. These tools are powerful but often siloed. They are great for the math, but terrible for the "writing and research" part of the job. This heor agent ai for health economics research from claude review finds that the agent occupies a unique middle ground: it’s a research assistant that can also talk to your modeling software.

Feature HEOR Agent (Claude) TreeAge Pro Cytel LiveSLR
Primary Strength Evidence Synthesis & Drafting Decision Tree/Markov Modeling Systematic Literature Review
AI Integration Native (Claude) Minimal/None Proprietary ML
Ease of Use Moderate (Requires MCP setup) Difficult (Steep learning curve) Easy (SaaS UI)
Data Sources 41+ (PubMed, Cochrane, etc.) User-provided Proprietary curated lists
HTA Templates NICE, EMA, FDA, HAS, IQWiG No Limited
Workflow Type Conversational/Agentic Visual/Mathematical Process-driven/Grid
Cost Open-source/API based High (Enterprise license) Very High (Subscription)

HEOR Agent vs. TreeAge Pro

Pick TreeAge if you need to build a highly complex, 20-state Markov model with probabilistic sensitivity analysis that will be scrutinized by a math-heavy committee. Pick the HEOR Agent if you need to gather the data to justify that model and then write the 100-page report that surrounds it. They are actually quite complementary.

HEOR Agent vs. Cytel LiveSLR

Cytel is the "safe" corporate choice. It is a polished SaaS product with a support team. The HEOR Agent is for the team that wants more flexibility and the power of Claude's reasoning. If you want a tool that can actually write the summary paragraphs, the HEOR Agent wins. If you want a tool that just organizes the search results in a grid, stick with Cytel.

Pro Tip: When using the agent for literature reviews, always ask it to "Provide a table of evidence with DOI links." This forces the agent to use its tool-calling capabilities rather than relying on its internal training data, which significantly reduces the risk of hallucinations.

Ready to Try heor agent ai for health economics research from claude?

You've seen the full picture. Now test it yourself β€” visit the official site to get started.

Visit heor agent ai for health economics research from claude β†’

Editorial Standards

This article was reviewed for accuracy by the Pidune editorial team. We maintain editorial independence β€” see our editorial standards and privacy policy.